Top

Published in:

01-06-2012 | IM - COMMENTARY

The FOUR score: is it just another new coma scale?

Author: Luis A. Idrovo Freire

Published in: Internal and Emergency Medicine | Issue 3/2012

Excerpt

The evaluation of a comatose patient is usually challenging. Within the complex spectrum of consciousness, scoring systems have been developed to obtain a fast and comprehensive assessment, to facilitate communication among examiners, to triage and monitor changes for therapeutic decisions, and to provide prognostic information [1, 2]. …

Teasdale G, Jennett B (1974) Assessment of coma and impaired consciousness: a practical scale. Lancet 2:81–84PubMedCrossRef

Kornbluth J, Bhardwaj A (2010) Evaluation of coma: a critical appraisal of popular scoring systems. Neurocrit Care 14(1):134–143CrossRef

Wijdicks EFM, Bamlet WR, Maramattom BV, Manno EM, McClelland RL (2005) Validation of a new coma scale: the FOUR score. Ann Neurol 58:585–593PubMedCrossRef

Balestreri M, Czosnyka M, Chatfield DA, Steiner LA, Schmidt EA, Smielewski P, Matta B, Pickard JD (2004) Predictive value of Glasgow Coma Scale after brain trauma: change in trend over the past ten years. J Neurol Neurosurg Psychiatry 75:161–162PubMed

Fugate JE, Rabinstein AA, Claassen DO, White RD, Wijdicks EFM (2010) The FOUR Score predicts outcome in patients after cardiac arrest. Neurocrit Care 13:205–210PubMedCrossRef

Rowley G, Fielding K (1991) Reliability and accuracy of the Glasgow Coma Scale with experienced and inexperienced users. Lancet 337:535–538PubMedCrossRef

Weiss N, Mutlu G, Essardy F, Nacabal C, Sauves C, Bally C, Houbert M, Lecorre C, Germack V, Demeret S, Pierrot-Deseilligny C, Bolgert F (2009) The French version of the FOUR score: a new coma score. Rev Neurol (Paris) 165:796–802CrossRef

Idrovo L, Fuentes B, Medina J, Gabaldón L, Ruiz-Ares G, Abenza MJ, Aguilar-Amat MJ, Martínez-Sánchez P, Rodríguez L, Cazorla R, Martínez M, Tafur A, Wijdicks EF, Diez-Tejedor E et al (2010) Validation of the FOUR Score (Spanish version) in acute stroke: an interobserver variability study. Eur Neurol 63:364–369PubMedCrossRef

Marcati E, Ricci S, Casalena A, Toni D, Carolei A, Sacco S (2011) Validation of the Italian version of a new coma scale: the FOUR score. Intern Emerg Med. doi:10.1007/s11739-011-0583-x

10.

Fischer M, Rüegg S, Czaplinski A, Strohmeier M, Lehmann A, Tschan F, Hunziker P, Marsch SC (2010) Inter-rater reliability of the Full Outline of UnResponsiveness score and the Glasgow Coma Scale in critical ill patients: a prospective observational study. Crit Care 14:R64PubMedCrossRef

11.

Kevric J, Jelinek GA, Knott J, Weiland TJ (2010) Validation of the Full Outline of Uresponsiveness (FOUR) scale for conscious state in the emergency department: comparison against the Glasgow Coma Scale. Emerg Med J Oct 13 (Epub ahead of print)

12.

Eken C, Kartal M, Bacanli A, Eray O (2009) Comparison of the Full Outline of UnResponsiveness Score Coma Scale and the Glasgow Coma Scale in an emergency setting population. Eur J Emerg Med 16:29–36PubMedCrossRef

13.

Stead LG, Wijdicks EFM, Bhagra A, Kashyap R, Bellolio MF, Nash DL, Enduri S, Schears R, William B (2009) Validation of a new coma scale, the FOUR Score, in the emergency department. Neurocrit Care 10:50–54PubMedCrossRef

14.

Iyer VN, Mandrekar JN, Danielson RD, Zubkov AY, Elmer JL, Wijdicks EFM et al (2009) Validity of the FOUR score coma scale in the medical intensive care unit. Mayo Clin Proc 84:694–701PubMedCrossRef

15.

Wolf CA, Wijdicks EFM, Bamlet WR, McClelland RL (2007) Further validation of the FOUR score coma scale by intensive care nurses. Mayo Clin Proc 82:435–438PubMedCrossRef

Title: The FOUR score: is it just another new coma scale?
Author: Luis A. Idrovo Freire
Publication date: 01-06-2012
Publisher: Springer Milan
Published in: Internal and Emergency Medicine / Issue 3/2012
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-011-0640-5

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2012

Right ventricular function predicts cardiovascular events in outpatients with stable cardiovascular diseases: preliminary results

Structural abnormalities of small resistance arteries in essential hypertension

Screening for asymptomatic coronary artery disease can reduce cardiovascular mortality and morbidity in type 2 diabetic patients

Melanonychia secondary to hydroxyurea

A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score

Weight loss is associated with improved endothelial dysfunction via NOX2-generated oxidative stress down-regulation in patients with the metabolic syndrome

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials